Migraine review for general practice
Tài liệu tham khảo
Goadsby, 2017, Pathophysiology of migraine: a disorder of sensory processing, Physiol Rev, 97, 553, 10.1152/physrev.00034.2015
Goadsby, 2019, An update: pathophysiology of migraine, Neurol Clin [Internet], 37, 651, 10.1016/j.ncl.2019.07.008
Maniyar, 2015, The premonitory phase of migraine – what can we learn from it?, Headache, 55, 609, 10.1111/head.12572
Kissoon, 2017, Aura and other neurologic dysfunction in or with migraine, Headache, 57, 1179, 10.1111/head.13101
Bose, 2018, The migraine postdrome, Contin Lifelong Learn Neurol, 24, 1023, 10.1212/CON.0000000000000626
Bigal, 2008, Clinical course in migraine: conceptualizing migraine transformation, Neurology, 71, 848, 10.1212/01.wnl.0000325565.63526.d2
May, 2016, Chronic migraine: risk factors, mechanisms and treatment, Nat Rev Neurol [Internet], 12, 455, 10.1038/nrneurol.2016.93
Evans, 2020, Neuroimaging for migraine: the American Headache Society systematic review and evidence-based guideline, Headache, 60, 318, 10.1111/head.13720
Lipton, 2015, Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine, Neurology, 84, 688, 10.1212/WNL.0000000000001256
Kelman, 2007, The triggers or precipitants of the acute migraine attack, Cephalalgia, 27, 394, 10.1111/j.1468-2982.2007.01303.x
Gaul, 2015, Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial, J Headache Pain, 16, 6, 10.1186/s10194-015-0516-6
Marmura, 2015, The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies, Headache, 55, 3, 10.1111/head.12499
Santos-Lasaosa, 2020
Dodick, 2004, Consensus statement: cardiovascular safety profile of triptans (5-HT 1B/1D agonists) in the acute treatment of migraine, Headache, 44, 414, 10.1111/j.1526-4610.2004.04078.x
Gladstone, 2004, Acute migraine: which triptan?, Pract Neurol, 4, 6, 10.1111/j.1474-7766.2004.03-205.x
Cameron, 2015, Triptans in the acute treatment of migraine: a systematic review and network meta-analysis, Headache, 55, 221, 10.1111/head.12601
Lipton, 2018, Migraine headache: diagnosis and current and emerging preventive treatments, Prim Care Companion CNS Disord, 20
Silberstein, 2015, Preventive migraine treatment, Contin Lifelong Learn Neurol, 21, 973, 10.1212/CON.0000000000000199
Carville, 2012, Diagnosis and management of headaches in young people and adults: Summary of NICE guidance, BMJ, 345, 1, 10.1136/bmj.e5765
Diener, 2007, Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study, Cephalalgia, 27, 814, 10.1111/j.1468-2982.2007.01326.x
Linde, 2013, Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults, Cochrane Database Syst Rev, 10.1002/14651858.CD010611
Silberstein, 2012, Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults report of the quality standards subcommittee of the American Academy of Neurology and the American Headache Society, Neurology, 78, 1337, 10.1212/WNL.0b013e3182535d20
Dorosch, 2019, Efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the preventative treatment of episodic migraine in adults, Curr Pain Headache Rep, 23, 10.1007/s11916-019-0823-8
Stubberud, 2019, Flunarizine as prophylaxis for episodic migraine: a systematic review with meta-analysis, Pain, 160, 762, 10.1097/j.pain.0000000000001456
Diener, 2010, OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial, Cephalalgia, 30, 804, 10.1177/0333102410364677
Santos Lasaosa, 2017, Consensus recommendations for anaesthetic peripheral nerve block, Neurologia, 32, 316, 10.1016/j.nrl.2016.04.017